| TITLE |
DATE |
PRICE |
| Biotech Equipment Update - August 2010 |
8/1/10 |
$25.00 |
|
|
| Worldwide Biotech - August 2010 |
8/1/10 |
$25.00 |
|
|
| Biotech Financial Reports - August 2010 |
8/1/10 |
$25.00 |
|
|
| Biotech Business - August 2010 |
8/1/10 |
$25.00 |
|
|
| Bioinformatics Market - Advanced Technologies, Global Forecast and Winning Imperatives (2009 - 2014) |
7/21/10 |
$4,650.00 |
|
|
| Human Embryonic Stem Cells (hESC) - A Global Market Overview |
7/21/10 |
$4,680.00 |
|
|
| Strategic Analysis of End-user Preferences in the U.S. Stem Cell Research Tools Markets |
7/19/10 |
$10,000.00 |
|
|
| Financial Health of the Biotechnology Industry |
7/13/10 |
$6,000.00 |
|
|
| Stakeholder Opinions: Ovarian Cancer - Approaching the era of molecular targeted therapy |
7/12/10 |
$3,800.00 |
|
|
| Advances in Imaging Biomarkers: Innovative technologies, applications in R&D and clinical practice, and informatics and regulatory requirements |
7/9/10 |
$3,835.00 |
|
|
| Biotechnology in the US - Industry Risk Rating Report |
7/6/10 |
$825.00 |
|
|
| Scientific Research & Development in the US - Industry Risk Rating Report |
7/6/10 |
$825.00 |
|
|
| Genzyme Corporation: PharmaVitae Profile |
7/5/10 |
$5,700.00 |
|
|
| Therapeutic Monoclonal Antibody Production |
7/1/10 |
$2,995.00 |
|
|
| Regenerative Medicine Markets |
7/1/10 |
$3,400.00 |
|
|
| Competitor Analysis: Antibody-Drug Conjugates (ADC) |
7/1/10 |
$503.00 |
|
|
| World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies) |
7/1/10 |
$4,500.00 |
|
|
| Biotechnology (Pharmaceuticals) Report |
7/1/10 |
$1,500.00 |
|
|
| Worldwide Biotech - July 2010 |
7/1/10 |
$25.00 |
|
|
| Biotech Financial Reports - July 2010 |
7/1/10 |
$25.00 |
|
|
| DNA Sequencing: Emerging Technologies and Applications |
7/1/10 |
$4,850.00 |
|
|
| Biotech Equipment Update - July 2010 |
7/1/10 |
$25.00 |
|
|
| Biotech Business - July 2010 |
7/1/10 |
$25.00 |
|
|
| Competitor Analysis: Anti-Infective Antibodies |
7/1/10 |
$1,011.00 |
|
|
| The Dynamic Media, Sera and Reagent Market in Biotechnology |
7/1/10 |
$4,850.00 |
|
|
| Cancer Drugs With Apoptotic Targets In Development |
7/1/10 |
$350.00 |
|
|
| Biotechnology in the UK |
6/30/10 |
$835.00 |
|
|
| Freedonia Focus on Nanotechnology in Health Care |
6/30/10 |
$500.00 |
|
|
| PAREXEL International Corporation - SWOT Analysis |
6/29/10 |
$125.00 |
|
|
| Biotechnology in the US - Industry Market Research Report |
6/29/10 |
$825.00 |
|
|
| Foreign Clinical Trial Review Concerns: A Contrarian Perspective |
6/29/10 |
$1,500.00 |
|
|
| Viscosupplementation - A European Market Snapshot |
6/29/10 |
$500.00 |
|
|
| Novozymes A/S in Ingredients - World |
6/29/10 |
$390.00 |
|
|
| Special Report: Newly Competitive Gaucher’s Disease Marketplace: Showcases Strategies for Rare Diseases |
6/28/10 |
$4,600.00 |
|
|
| Mastering Biomarkers: Five Top Diagnostics Companies to Watch |
6/28/10 |
$2,300.00 |
|
|
| Maxygen, Inc. - SWOT Analysis |
6/25/10 |
$125.00 |
|
|
| PDL Biopharma, Inc. - SWOT Analysis |
6/25/10 |
$125.00 |
|
|
| Triple Analysis: Prostate Cancer, Antibodies and Peptides |
6/24/10 |
$5,003.00 |
|
|
| Triple Analysis: Cancer Vaccines, Antibodies and Peptides |
6/24/10 |
$5,003.00 |
|
|
| Biological products, except diagnostic: State Industry Market Evaluator |
6/20/10 |
$399.00 |
|
|
| Biological products, except diagnostic: Metro Industry Market Evaluator |
6/20/10 |
$499.00 |
|
|
| Biological products, except diagnostic: Industry Cluster Report |
6/20/10 |
$440.00 |
|
|
| Analytical Laboratory Instrument Manufacturing Industry in the U.S. and its International Trade [2010 Edition] |
6/14/10 |
$599.00 |
|
|
| Special Report: Acute Lymphocytic Leukemia—Unmet Needs in Adult and Pediatric Populations Drive Recent Market Developments |
6/14/10 |
$4,600.00 |
|
|
| Elan Corporation, plc - SWOT Analysis |
6/10/10 |
$125.00 |
|
|
| Biotechnology Sector |
6/7/10 |
$129.00 |
|
|
| Biotech Investment and Business Trends: Weathering the Economic Storm |
6/3/10 |
$2,300.00 |
|
|
| Biotechnology in Australia - Industry Market Research Report |
6/2/10 |
$760.00 |
|
|
| Nanotechnology in Health Care |
6/1/10 |
$4,800.00 |
|
|
| Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 4th Edition |
6/1/10 |
$3,995.00 |
|
|
| Option and Evaluation Agreements in Pharma and Biotech |
6/1/10 |
$2,495.00 |
|
|
